The practice of Next Generation Sequencing (NGS) is the new buzz word in oncology practice. Regarded as the next horizon in cancer diagnostics, Next-Generation Sequencing (NGS) is gaining importance as it allows for a comprehensive analysis of an individual’s tumor DNA, providing insights into the specific genetic changes driving the tumor and informing treatment options.
How does digital technology play a crucial role in oncology services? Listen in to this podcast as R. Venkataramanan, Founder, Karkinos Healthcare and Girish Raghavan, VP, GE Healthcare, talk about the role of digital technologies and AI in Cancer Care.
In this exclusively compiled article for ETHealthWorld, Dr. Moni Abraham K., Co-Founder, Medical Director, Karkinos Kerala, and R Venkataramanan, Founder and CEO, Karkinos Healthcare, elaborate on how technology offers several advantages to address disparities in cancer care.
The joint initiative will provide access to potentially life-saving Cancer Screening facilities to those belonging to economically backward categories, as they are the ones who need such facilities the most, due to a lack of awareness and funds for such tests.
Decentralization has the potential to address some of the greatest challenges in cancer care that can directly result in better outcomes for citizens and patients, while simultaneously reducing the financial burden.
